What is the dose of Lecovorin (folinic acid) in the medical management of ectopic pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Leucovorin Dosing in Medical Management of Ectopic Pregnancy

Leucovorin (folinic acid) is NOT routinely recommended in the standard medical management of ectopic pregnancy with methotrexate, as the single-dose methotrexate protocol (50 mg/m² IM) without leucovorin rescue has become the preferred approach with lower toxicity and excellent efficacy. 1, 2

Standard Methotrexate Protocol (Without Leucovorin)

The current evidence-based approach for ectopic pregnancy does not include leucovorin:

  • Single-dose methotrexate 50 mg/m² IM is the standard treatment, with repeat dosing on day 7 if β-hCG levels do not decrease appropriately 3, 1
  • This protocol achieves success rates of 88.1% for single-dose regimens and 92.7% for multiple-dose regimens without leucovorin rescue 3
  • The single-dose regimen without leucovorin has been associated with lower frequency of toxicity compared to multi-dose protocols that included leucovorin 2

Historical Multi-Dose Protocol (With Leucovorin)

When leucovorin was used historically, the dosing was:

  • Leucovorin 0.1 mg/kg IM given after each methotrexate dose in older multi-dose protocols 4
  • Alternatively, leucovorin 15 mg orally 30 hours after each methotrexate injection was used to reduce side effects 5
  • This approach involved methotrexate 1.0 mg/kg IV followed by leucovorin rescue on alternate days 4

Why Leucovorin Is Not Used in Current Practice

The shift away from leucovorin in ectopic pregnancy management occurred because:

  • Single-dose methotrexate without leucovorin is safer with fewer gastrointestinal side effects (stomatitis, gastritis) and hepatotoxicity 2
  • Success rates remain excellent (71-95%) without leucovorin rescue 6
  • The simpler protocol improves patient compliance and reduces treatment complexity 1

Important Clinical Caveat

Folic acid supplements must be avoided during methotrexate treatment as they counteract methotrexate's action, which is the opposite of what leucovorin would do 1, 5

When Leucovorin Might Be Considered

Leucovorin rescue is reserved for:

  • Molar pregnancy treatment with intensive multi-dose methotrexate regimens (15 mg orally 30 hours after each methotrexate dose) 5
  • High-risk gestational trophoblastic disease requiring EMA/CO chemotherapy protocols 5
  • Cases of methotrexate toxicity requiring rescue therapy (not routine prophylaxis)

In summary, do not administer leucovorin for routine ectopic pregnancy management with methotrexate—use the standard single-dose protocol of 50 mg/m² IM without leucovorin rescue. 1, 2

References

Guideline

Methotrexate Treatment for Unruptured Ectopic Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Conservative treatment of ectopic pregnancy with methotrexate.

American journal of obstetrics and gynecology, 1986

Guideline

Methotrexate Dosing for Molar Pregnancy Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ectopic Pregnancy Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.